Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.
Scientists from Argonne National Laboratory and Northwestern University have produced 10 distinct crystal compounds from a single chemical formula by strategically swapping elements in a crystal ...